Skip to main content

Tokyo court rejects Oishii Farm's claim to a strawberry patent and penalises its press release

Tokyo District Court dismissed Oishii Farm's claim to MD-Farm's strawberry patent and ordered 2.2 million yen over its own press release.

Tokyo court rejects Oishii Farm's claim to a strawberry patent and penalises its press release

The Tokyo District Court ruled on 29 October 2026, in case Reiwa 6 (Wa) No. 70618, that Oishii Farm Corporation has no claim to Japanese Patent No. 7551158, a method for cultivating strawberries held by MD-Farm. Every claim Oishii brought, which sought transfer of the patent and related relief, was dismissed. MD-Farm, based in Niigata Prefecture and led by president and chief executive Yuki Matsuda, announced the outcome in a press release on 30 October. Oishii published its own notice of the judgment in the same week, and VerticalFarmDaily reported the ruling on 2 November drawing on both statements.

The second half of the judgment went against Oishii as well. MD-Farm had counterclaimed over a press release Oishii published about the dispute, and the court found that the release amounted to damage to business credibility under Article 2, paragraph 1, item 21 of Japan's Unfair Competition Prevention Act. It ordered Oishii to stop communicating the specified statements to third parties and to pay 2.2 million yen plus late payment damages. MD-Farm had sought 24.53 million yen, and the remainder of its counterclaim, including a demand that Oishii publish an apology notice, was dismissed. Oishii says it has since taken the earlier release off its website in line with the judgment.

On the substance the court did not accept that Yuki Matsuda conceived or completed the invention while he was at Oishii, nor that he took or misused technical information on his way out. That finding decided the ownership question. Oishii, for its part, says the scope of the patent was narrowed during the proceedings, and that it has decided not to appeal the dismissal of its own claim because it considers further litigation unproductive. It also states that the patent is unrelated to the technology it uses, and that two law firms, Nagashima Ohno & Tsunematsu before the suit and Nishimura & Asahi after the ruling, have given opinions to that effect.

One front remains open. Oishii filed a separate damages suit on 6 January 2025, alleging that Matsuda breached a settlement agreement by selling information, and the company expects a judgment next year. The patent at the centre of the decided case covers continuous flowering, the technique of keeping strawberry plants in fruit through the year rather than in one season, which is the economic core of indoor strawberry production. Oishii runs a plant factory in Hamura, in western Tokyo, alongside its operations in the United States. MD-Farm keeps the patent, a clean finding on inventorship and a judgment it can point to.

Why it matters for AgTech founders: there are three things to take away here, and the cheapest one is the second. First, the ordinary discipline of inventorship. Ownership of a patent filed by a departing employee turns on who conceived the invention and when, and that is settled on dated records, assignment clauses and laboratory notebooks, not on how obvious the story feels inside the company. If your position depends on an argument nobody wrote down at the time, you do not have an IP position, you have a hypothesis. Second, and this is the part that cost real money, Oishii lost 2.2 million yen and an injunction not because of what it filed in court but because of what it put on its website about the filing. Litigation communications are a separate legal product from the litigation itself, and in Japan, as in several European jurisdictions, a confident public statement about a competitor can be actionable on its own while the underlying case is still open. Have the same counsel who drafted the complaint read the press release. Third, a strategic point. Oishii now says the patent was never relevant to its technology and that it holds opinions saying so, which invites the question of what the action was meant to achieve. Founders holding a defensive portfolio should be candid about which filings they would genuinely litigate over, and should price the management time and reputational cost of the ones they would not.

Source: VerticalFarmDaily

Tokyo court rejects Oishii Farm's claim to a strawberry patent and penalises its press release

The Tokyo District Court dismissed every claim Oishii Farm brought over MD-Farm's continuous flowering patent, then ordered it to pay 2.2 million yen because of the statement it had published about the case.

By Dirk Vandenhirtz

· CEA / Vertical Farming · Asia Pacific · 4 min

The Tokyo District Court ruled on 29 October 2026, in case Reiwa 6 (Wa) No. 70618, that Oishii Farm Corporation has no claim to Japanese Patent No. 7551158, a method for cultivating strawberries held by MD-Farm. Every claim Oishii brought, which sought transfer of the patent and related relief, was dismissed. MD-Farm, based in Niigata Prefecture and led by president and chief executive Yuki Matsuda, announced the outcome in a press release on 30 October. Oishii published its own notice of the judgment in the same week, and VerticalFarmDaily reported the ruling on 2 November drawing on both statements.

The second half of the judgment went against Oishii as well. MD-Farm had counterclaimed over a press release Oishii published about the dispute, and the court found that the release amounted to damage to business credibility under Article 2, paragraph 1, item 21 of Japan's Unfair Competition Prevention Act. It ordered Oishii to stop communicating the specified statements to third parties and to pay 2.2 million yen plus late payment damages. MD-Farm had sought 24.53 million yen, and the remainder of its counterclaim, including a demand that Oishii publish an apology notice, was dismissed. Oishii says it has since taken the earlier release off its website in line with the judgment.

On the substance the court did not accept that Yuki Matsuda conceived or completed the invention while he was at Oishii, nor that he took or misused technical information on his way out. That finding decided the ownership question. Oishii, for its part, says the scope of the patent was narrowed during the proceedings, and that it has decided not to appeal the dismissal of its own claim because it considers further litigation unproductive. It also states that the patent is unrelated to the technology it uses, and that two law firms, Nagashima Ohno & Tsunematsu before the suit and Nishimura & Asahi after the ruling, have given opinions to that effect.

One front remains open. Oishii filed a separate damages suit on 6 January 2025, alleging that Matsuda breached a settlement agreement by selling information, and the company expects a judgment next year. The patent at the centre of the decided case covers continuous flowering, the technique of keeping strawberry plants in fruit through the year rather than in one season, which is the economic core of indoor strawberry production. Oishii runs a plant factory in Hamura, in western Tokyo, alongside its operations in the United States. MD-Farm keeps the patent, a clean finding on inventorship and a judgment it can point to.

Why it matters for AgTech founders: there are three things to take away here, and the cheapest one is the second. First, the ordinary discipline of inventorship. Ownership of a patent filed by a departing employee turns on who conceived the invention and when, and that is settled on dated records, assignment clauses and laboratory notebooks, not on how obvious the story feels inside the company. If your position depends on an argument nobody wrote down at the time, you do not have an IP position, you have a hypothesis. Second, and this is the part that cost real money, Oishii lost 2.2 million yen and an injunction not because of what it filed in court but because of what it put on its website about the filing. Litigation communications are a separate legal product from the litigation itself, and in Japan, as in several European jurisdictions, a confident public statement about a competitor can be actionable on its own while the underlying case is still open. Have the same counsel who drafted the complaint read the press release. Third, a strategic point. Oishii now says the patent was never relevant to its technology and that it holds opinions saying so, which invites the question of what the action was meant to achieve. Founders holding a defensive portfolio should be candid about which filings they would genuinely litigate over, and should price the management time and reputational cost of the ones they would not.

Source: VerticalFarmDaily

Back to AgTech News